169 related articles for article (PubMed ID: 25054966)
1. Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study.
Vaz-de-Melo RO; Giollo-Júnior LT; Martinelli DD; Moreno-Júnior H; Mota-Gomes MA; Cipullo JP; Yugar-Toledo JC; Vilela-Martin JF
Sao Paulo Med J; 2014; 132(5):290-6. PubMed ID: 25054966
[TBL] [Abstract][Full Text] [Related]
2. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
Polónia J; Barbosa L; Silva JA; Bertoquini S
Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness.
Kampus P; Serg M; Kals J; Zagura M; Muda P; Karu K; Zilmer M; Eha J
Hypertension; 2011 Jun; 57(6):1122-8. PubMed ID: 21536983
[TBL] [Abstract][Full Text] [Related]
4. Central hemodynamics in prehypertension: effect of the β-adrenergic antagonist nebivolol.
Davis JT; Pasha DN; Khandrika S; Fung MM; Milic M; O'Connor DT
J Clin Hypertens (Greenwich); 2013 Jan; 15(1):69-74. PubMed ID: 23282127
[TBL] [Abstract][Full Text] [Related]
5. [Prospective follow-up of nebivolol in the treatment of arterial hypertension].
Despotović N; Matić-Cvetković D; Ivanović B
Srp Arh Celok Lek; 2012; 140(7-8):425-30. PubMed ID: 23092025
[TBL] [Abstract][Full Text] [Related]
6. Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study.
Redón J; Pascual-Izuel JM; Rodilla E; Vicente A; Oliván J; Bonet J; Torguet JP; Calaforra O; Almirall J
Blood Press; 2014 Jun; 23(3):181-8. PubMed ID: 24059690
[TBL] [Abstract][Full Text] [Related]
7. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
Weiss RJ; Stapff M; Lin Y
Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of nebivolol: does age matter? A retrospective analysis of three randomized, placebo-controlled trials in stage I-II hypertension.
Germino FW; Lin Y; Pejović V; Bowen L
Ther Adv Cardiovasc Dis; 2012 Oct; 6(5):185-99. PubMed ID: 23008339
[TBL] [Abstract][Full Text] [Related]
9. Effects of nebivolol on aortic compliance in patients with diabetes and maximal renin angiotensin system blockade: the EFFORT study.
Briasoulis A; Oliva R; Kalaitzidis R; Flynn C; Lazich I; Schlaffer C; Bakris G
J Clin Hypertens (Greenwich); 2013 Jul; 15(7):473-9. PubMed ID: 23815535
[TBL] [Abstract][Full Text] [Related]
10. Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function.
Merchant N; Searles CD; Pandian A; Rahman ST; Ferdinand KC; Umpierrez GE; Khan BV
J Clin Hypertens (Greenwich); 2009 Dec; 11(12):720-5. PubMed ID: 20021529
[TBL] [Abstract][Full Text] [Related]
11. Nebivolol: impact on cardiac and endothelial function and clinical utility.
Toblli JE; DiGennaro F; Giani JF; Dominici FP
Vasc Health Risk Manag; 2012; 8():151-60. PubMed ID: 22454559
[TBL] [Abstract][Full Text] [Related]
12. The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension.
Lefebvre J; Poirier L; Poirier P; Turgeon J; Lacourciere Y
Br J Clin Pharmacol; 2007 May; 63(5):575-82. PubMed ID: 17094780
[TBL] [Abstract][Full Text] [Related]
13. Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial.
Lewin A; Punzi H; Luo X; Stapff M
Clin Ther; 2013 Feb; 35(2):142-52. PubMed ID: 23332366
[TBL] [Abstract][Full Text] [Related]
14. The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients.
Tarighi B; Kurum T; Demir M; Azcan SN
Can J Cardiol; 2007 Jun; 23(8):651-5. PubMed ID: 17593991
[TBL] [Abstract][Full Text] [Related]
15. Aortic elastic properties : effects of carvedilol versus nebivolol.
Sayin MR; Aydin M; Dogan SM; Karabag T; Cetiner MA; Aktop Z
Herz; 2013 May; 38(3):299-305. PubMed ID: 23263241
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
Brixius K; Middeke M; Lichtenthal A; Jahn E; Schwinger RH
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):327-31. PubMed ID: 17324145
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
Germino FW
Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
[TBL] [Abstract][Full Text] [Related]
18. Singular and combined effects of nebivolol and lifestyle modification on large artery stiffness in hypertensive adults.
Werner TJ; Boutagy NE; Osterberg KL; Rivero JM; Davy KP
Ther Adv Cardiovasc Dis; 2013 Dec; 7(6):285-92. PubMed ID: 24265181
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study.
Rosei EA; Rizzoni D; Comini S; Boari G;
Blood Press Suppl; 2003 May; 1():30-5. PubMed ID: 12800985
[TBL] [Abstract][Full Text] [Related]
20. Role of nebivolol in the control and management of central aortic blood pressure in hypertensive patients.
Borghi C; Acelajado MC; Gupta Y; Jain S
J Hum Hypertens; 2017 Oct; 31(10):605-610. PubMed ID: 28382958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
